EquityFlowCompanies › ARK

ARK

Healthtech · KR

AI screening systems for early detection of chronic disease complications

Funding history

DateRoundAmount
Mar 2026Series A
ARK completed a KRW 20 billion (~$14M) Series A to expand its AI screening of chronic disease complications, already supplied to over 700 Korean healthcare facilities.
$14M

Similar companies in Healthtech

Explore funding flow on EquityFlow →